An analysis of COVID-19 testing in the Baltimore-Washington metropolitan area of the United States found that Latinx people were around three times as likely to test positive, compared with any other ethnic or racial group. All data and statistics are based on publicly available data at the time of publication. Some information may be out...
DALLAS, July 13, 2020 — Women taking beta blockers for hypertension with no prior history of cardiovascular disease (CVD) have a nearly 5% higher risk for heart failure than men when they present to hospital with acute coronary syndrome, according to new research published today in Hypertension, an American Heart Association journal. Beta blockers are...
NEW YORK INSTITUTE OF TECHNOLOGY Biomedical experts believe that half of heart failure patients likely have low levels of the thyroid hormone T3 in their cardiac tissue. While heart failure symptoms are commonly attributed to cardiovascular conditions like coronary artery disease and high blood pressure, a growing number of studies suggest that low cardiac T3...
by University of Illinois at Chicago UIC’s Xiaoping Du oversees Ph.D. student Yaping Zhanga enter a sample in an aggregometer in his lab at the College of Medicine Research Building Credit: Joshua Clark/University of Illinois at Chicago Researchers at the University of Illinois at Chicago have developed a new drug that prevents blood clots without...
by UT Southwestern Medical Center A new report from cardiologists at UT Southwestern raises the hope that doctors will be able to visually check the jugular venous pressure of heart failure patients remotely, using the camera on a smartphone. The finding is especially timely as telemedicine expands during the pandemic. The jugular venous pressure assessment,...
Circulation: Cardiovascular quality and outcomes journal report AMERICAN HEART ASSOCIATION DALLAS, June 23, 2020 — Heart failure posed the greatest 5-year risk of death for people newly diagnosed with Type 2 diabetes than any other heart or kidney diseases, according to new research published today in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association...
EUROPEAN SOCIETY OF CARDIOLOGY CLINICALLY, THERE ARE DIFFERENCES IN TONGUE IMAGES, INCLUDING TONGUE COATING AND TONGUE COLOUR BETWEEN CHRONIC HEART FAILURE (CHF) PATIENTS AND HEALTHY INDIVIDUALS. RECENT REPORTS HAVE SUGGESTED ALTERATIONS IN THE TONGUE… view more CREDIT: @EUROPEAN SOCIETY OF CARDIOLOGY 2020 Sophia Antipolis – 23 June 2020: Microorganisms on the tongue could help diagnose...
EUROPEAN SOCIETY OF CARDIOLOGY Sophia Antipolis – 19 June 2020: Voice analysis by a smartphone app identifies lung congestion in heart failure patients, allowing early intervention before their condition deteriorates. The small study is presented today on HFA Discoveries, a scientific platform of the European Society of Cardiology (ESC).1 “Speech is personal and as such,...
by Wiley Heart failure and cancer are conditions with a number of shared characteristics. A new study published in the Journal of Internal Medicine found that in patients with heart failure, several known tumor markers can also be indicators of heart failure severity and progression. In the study, researchers measured six markers that are indicators...
The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday. Farxiga is the first approved sodium-glucose cotransporter 2 inhibitor to treat adults with New York Heart Association functional class II to IV heart failure with reduced ejection...
